Diaphragmmatic Muscle Strength and Balance in Women With Dysmenorhea (Dysmenorhea)

January 26, 2024 updated by: Felipe León Morillas, Catholic University of Murcia
Analysis of stabilometric and respiratory variables in patients with dysmenorrhea during the first day of the menstrual cycle and any other day outside the cycle.

Study Overview

Status

Completed

Detailed Description

Sociodemographic variables such as age, height, body mass index.

Respiratory variables such as maximum inspiratory pressure (MIP), MIP reference %, and MIP predictive value.

Stabilometric variables we will measure the balance in condition of eyes open and eyes closed bipodal support and eyes open in monopodal support

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Murcia
      • Guadalupe, Murcia, Spain, 30107
        • University Catholic of Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Women with primary dysmenorrhea

Description

Inclusion Criteria:

  • Adult women with primary dysmenorrhea.
  • Not having had any type of childbirth (natural, caesarean section, etc).
  • Not be positive in COVID. Antigen test in the last 24 hours or negative PCR in the last 48 hours.

Exclusion Criteria:

  • Receive medical treatment during research.
  • Have any orthopedic, neurological or systemic disease diagnosed other than primary dysmenorrhea.
  • Be in follow-up with any medical treatment that does not be primary dysmenorrhea
  • Women with a history of trauma or surgical treatment who involve the musculoskeletal system in the last year.
  • Use of analgesics in the last 48 hours.
  • Consumption of alcohol in the last 24 hours.
  • Have a history or suspicion of pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
dysmenorrhea
primary dysmenorrhea
control
control not pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: 2 months
stabilometric variables in bipodal and monopodal support
2 months
diaphragmatic muscle strength
Time Frame: 2 months
diaphragmatic muscle force through the maximum inspiratory pressure in the mouth
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sociodemographic variables
Time Frame: 2 monsths
sociodemographic variables such as age, body mass index, personal data record, and data record related to pain and dysmenorrhea
2 monsths

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Felipe León-Morillas, Catholic University of Murcia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2023

Primary Completion (Actual)

June 14, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

May 23, 2023

First Submitted That Met QC Criteria

May 23, 2023

First Posted (Actual)

June 2, 2023

Study Record Updates

Last Update Posted (Actual)

January 29, 2024

Last Update Submitted That Met QC Criteria

January 26, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dysmenorrhea Primary

Subscribe